fda status bpc-157 compounding pharmacies 2026 Big news for the peptide space. The Pharmacy Advisory Committee recently voted eight to six in favor of allowing compounding to produce BPC 157. Here is what you need This is the first vote

This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make FDA's July 2026 Peptide Compounding Meeting: What PCAC Could Change for BPC 157, TB 500, Semax, and More PeptideKnow 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval FDA's Review Of Peptides Signals A Growing Public Health Challenge

SKU: 89779240340 · From iglepidom.org